- Q1 2024 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2024$11.65 (-0.94%)Earnings
- Q4 2023 Dynavax Technologies Corp Earnings Call TranscriptFeb 22, 2024$12.44 (-0.16%)Earnings
- Dynavax Technologies Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Dynavax Technologies Corp Earnings Call TranscriptNov 02, 2023$14.07 (-0.21%)Earnings
- Dynavax Technologies Corp at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Q2 2023 Dynavax Technologies Corp Earnings Call TranscriptAug 03, 2023$13.39 (-1.11%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Dynavax Technologies Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Dynavax Technologies Corp at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Dynavax Technologies Corp Earnings Call TranscriptMay 02, 2023$10.31 (-2.00%)Earnings
- Q4 2022 Dynavax Technologies Corp Earnings Call TranscriptFeb 23, 2023$10.77 (-1.19%)Earnings
- Q3 2022 Dynavax Technologies Corp Earnings Call TranscriptNov 03, 2022$11.17 (-0.89%)Earnings
- Q2 2022 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2022$14.34 (+1.49%)Earnings
- Q1 2022 Dynavax Technologies Corp Earnings Call TranscriptMay 05, 2022$8.76 (-6.21%)Earnings
- Q4 2021 Dynavax Technologies Corp Earnings Call TranscriptFeb 28, 2022$12.26 (-1.76%)Earnings
- Q3 2021 Dynavax Technologies Corp Earnings Call TranscriptNov 04, 2021$20.76 (-0.86%)Earnings
- Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2021$9.88 (+1.44%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2021
- Q1 2021 Dynavax Technologies Corp Earnings Call TranscriptMay 06, 2021$8.88 (-0.67%)Earnings
- Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Dynavax Technologies Corp Earnings Call TranscriptFeb 25, 2021$8.16 (-13.01%)Earnings
- Q3 2020 Dynavax Technologies Corp Earnings Call TranscriptNov 05, 2020$4.13Earnings
- Q2 2020 Dynavax Technologies Corp Earnings Call TranscriptAug 06, 2020$8.82 (-1.89%)Earnings
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Dynavax Technologies Corp Earnings Call TranscriptMay 07, 2020$4.54 (-2.58%)Earnings
- Dynavax Technologies Corp - To Discuss the Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B - Conference Call TranscriptApr 30, 2020
- Q4 2019 Dynavax Technologies Corp Earnings Call TranscriptMar 11, 2020$3.07 (-18.13%)Earnings
- Q3 2019 Dynavax Technologies Corp Earnings Call TranscriptNov 06, 2019$5.23 (-2.43%)Earnings
- Q2 2019 Dynavax Technologies Corp Earnings Call TranscriptAug 07, 2019$2.99 (+3.82%)Earnings
- Q1 2019 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2019$6.53 (+0.31%)Earnings
- Q4 2018 Dynavax Technologies Corp Earnings Call TranscriptFeb 26, 2019$10.56 (+1.93%)Earnings
Dynavax Technologies Corp Annual Shareholders Meeting Transcript
Ladies and gentlemen, I would like to welcome you to the virtual 2020 Annual Meeting of our Stockholders of Dynavax Technologies Corporation. I'm Ryan Spencer, Chief Executive Officer.
We are holding our 2020 Annual Meeting virtually this year due to the public health risk related to COVID-19. This format ensures the health and safety of all participants. In keeping with the digital approach to this year's meeting, it is now shortly after 9 a.m. Pacific Standard Time on May 28, and this meeting is officially called to order.
We are very pleased to have with us today all members of our Board of Directors, along with Michael Ostrach, our CFO; and Steve Gersten, our General Counsel and Corporate Secretary. In addition, Darcy Lopes of Ernst & Young LLP; and Steven Przesmicki from Cooley LLP, the company's outside counsel, are with us and will be available to respond to appropriate questions.
With that, I will now turn the meeting over to Steve Gersten.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)